FindTrial
Sign In

The Role of Saraswata Churna and Ashwagandha Ghrita in the management of depressive disorder (Undmada)

An Open Randomized Control Clinical study on efficacy of Saraswata Churna and Ashwagandha Ghrita in the management of Kaphaja Unmada w.s.r. depressive disorders

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/12/038595
Enrollment
120
Registered
2021-12-13
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F330- Major depressive disorder, recurrent, mild

Interventions

None listed

Sponsors

Shri Krishna AYUSH University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Age groups 30-75 years of either sex, no discrimination of caste and religion 2 Hamiltonâ??s Depression Rating Scale and Ayurvedic Assessment Scale in Kaphaja Unmada diagnostic criteria for mood disorder due to general medical Condition of Unmada with depressive features.

Exclusion criteria

Exclusion criteria: 1 Patient with a history of hereditary or previous mental disorders 2 Unconscious & coma patients 3 Intracranial infections such as Meningitis 4 Space occupying lesions of the brain such as tumours 5 Stroke due to RTA, Traumas 6 Congenital defects- diffuse sclerosis, cerebral agenesis, etc. & other major illness 7 Events promoting depression other than the impact of Kaphaja Unmada

Design outcomes

Primary

MeasureTime frame
To rule out the significant result of Saraswata Churna and Ashwagandha Ghrita in the management of Kaphaja Unmada w.s.r. depressive disordersTimepoint: 8 weeks—

Secondary

MeasureTime frame
To rule out the significant result of Ashwagandha Ghrita in the management of Kaphaja Unmada w.s.r. depressive disordersTimepoint: 8 weeks;To rule out the significant result of Saraswata Churna in the management of Kaphaja Unmada w.s.r. depressive disordersTimepoint: 8 weeks—

Countries

India

Contacts

Public ContactProf Balbir Singh Sandhu

Shri Krishna AYUSH University

balbirsandhu63@gmail.com9813063424

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026